Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-01

Clinical Trial Update: A Trial Comparing the Two High-dose Chemotherapies BeEAM and BEAM Given Before Autologous Stem Cell Transplantation (ASCT) in Lymphoma Patients (BEB-trial) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing BeEAM and BEAM high-dose chemotherapy regimens before autologous stem cell transplantation in lymphoma patients; the study is completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUSULFAN (Busulfan)
  • CYTARABINE (CYTARABINE)
  • Carmustine (carmustine)
  • Etoposide (Etoposide)
  • Melphalan (Melphalan)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular | Phase 2 | Status: COMPLETED | Results posted: 2025-08-01